In plaintiff's case against the defendant for misappropriation of its trade secrets of an anti-viral protein based therapeutic used as a daily nasal spray for the prevention and treatment of the common cold, plaintiff's petition for a writ of mandate to compel the trial court to accept plaintiff's trade secret identification statement as sufficient and to allow it to commence discovery is denied where: 1) the trial court applied the correct legal standard to plaintiff's trade secret identification statement; and 2) there was a basis in the record to support the court's conclusion that the statement was not reasonably particular under the circumstances presented.
Filed November 6, 2009
Opinion by Judge Ikola
For Appellant: Kirby Noonan Lance & Hoge, Michael L. Kirby, Jacob M. Slania, and Julianne Hull
For Appellee: N/A